Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $16.85 USD
Change Today -0.69 / -3.93%
Volume 921.7K
HALO On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

H. Michael Shepard Ph.D.

AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 2 different industries.

See Board Relationships
65--
As of Fiscal Year 2013

Background*

Dr. H. Michael Shepard, Ph.D. founded Receptor BioLogix, Inc. in 2003 and has been its President and Chief Scientific Officer since June 2006. Dr. Shepard served as the Chief Scientific Officer and Vice President of Halozyme Therapeutics, Inc. from December 3, 2010 to August 2015. He served as Vice President Of Discovery Research at Halozyme Therapeutics, Inc., from June 2009 to December 3, 2010. He served as Chief Executive Officer of Receptor BioLogix Inc. He has an ...

Read Full Background

Corporate Headquarters*

11388 Sorrento Valley Road
San Diego, California 92121

United States

Phone: 858-794-8889
Fax: 858-704-8311

Board Members Memberships*

Founder, President, Chief Scientific Officer and Director

Education*

Unknown/Other Education
Indiana University, Bloomington
PhD
Indiana University, Bloomington
Bachelor's Degree
University of California - Davis School of Law

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HALO:US $16.85 USD -0.69

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HALOZYME THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.